StartUp Health NOW Podcast

StartUp Health NOW Podcast
StartUp Health NOW Podcast Podcast

StartUp Health NOW celebrates the innovators, industry leaders, and entrepreneurs who are reimagining health and wellness.

  1. 12 SEPT

    From Caregiver to Changemaker: Inside the Impact Board with Meryl Comer on Fighting Alzheimer’s

    This week on StartUp Health NOW, we meet a powerful force in the fight against Alzheimer's disease: Meryl Comer, a member of our Alzheimer's Moonshot Impact Board. Driven by personal experience watching her husband battle the disease, Comer transformed from award-winning journalist to passionate advocate. She is the Co-founder & Board Member of UsAgainstAlzheimers; the U.S. Representative for the Global Brain Trust; and Vice-Chair of WHAM (Women’s Health Access Matters). Hear her story: Witnessing the devastating effects of Alzheimer's firsthand Taking action through co-founding UsAgainstAlzheimers The critical role of advocacy and policy change The emotional and physical burden of caregiving Comer also shares her insights on: Destigmatizing Alzheimer's diagnosis Anchoring innovation in the realities of care Treating the source of the disease This episode is a must-listen for anyone affected by Alzheimer's, passionate about healthcare innovation, or inspired by the power of advocacy.   Are you ready to join a Health Moonshot Community? Members of our Health Moonshot Communities – like our Alzheimer's Moonshot – are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. Learn more and apply today. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

  2. 30 AUG

    Bridging the Divide: How Mindr Is Bringing Alzheimer’s Research to Life

    Alzheimer's disease has long been a formidable challenge, but recent scientific breakthroughs offer a glimmer of hope. The FINGER study, a landmark in Alzheimer's research, demonstrated the power of simple lifestyle changes in preventing cognitive decline. However, translating these findings into practical, everyday strategies has proven elusive. In this episode of StartUp Health NOW, we explore how Mindr, a pioneering startup in our Alzheimer’s Moonshot Community, is bridging the gap between research – the FINGER study – and real-world application in the lives of people at risk for Alzheimer’s and dementia. By leveraging the best of modern consumer tech – like a well designed app on your phone – Mindr aims to make internationally-recognized advances in healthcare accessible to everyone. This is a story that applies in almost every area of health. We have the information, but we struggle to get it out of the lab, out of the peer reviewed journal, and into everyday life. Mindr's co-founders Adam Schultz and Ariana Myers explain how they’re attempting to bridge this divide and what it will take to succeed on a bigger scale. Join us as we discuss the importance of connecting research to practice and how Mindr is empowering individuals to take proactive steps toward a healthier brain. Innovating in Alzheimer’s disease? Learn how you can join our Alzheimer’s Moonshot. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.

  3. 15 AUG

    American Diabetes Association Launches Obesity Association

    In this episode of StartUp Health NOW, Chuck Henderson, the CEO of the American Diabetes Association (ADA) and a member of StartUp Health's Health Moonshot Impact Board, took time out of his busy schedule at the recent ADA Scientific Sessions – the ADA’s annual global gathering of more than 11,000 people working on foundational products and bleeding-edge ideas related to both Type 1 and Type 2 diabetes – to chat with us about innovation, collaboration, and the ADA's latest initiatives. Launch of the Obesity Association: The ADA has announced the formation of the Obesity Association, which will now be a division within the ADA, focusing heavily on integrating obesity care into diabetes standards. Cutting-Edge Research: The ADA is doubling down on its efforts to combat obesity by incorporating it more thoroughly into their standards of care, considered a critical resource in diabetes management. Health Equity: A significant focus is on health equity, ensuring that all programs are accessible and beneficial to underserved communities, including rural areas. Community Outreach: The ADA has initiated programs like mobile clinics in rural Alabama to address diabetic retinopathy, demonstrating their commitment to reaching underserved populations. Innovation and Competition: The ADA values innovation and competition, fostering early-stage research and encouraging disruptive ideas to push forward diabetes care and treatment. Collaboration with StartUp Health: Chuck Henderson expressed his appreciation for his involvement with StartUp Health. He highlights StartUp Health's role in connecting communities and emphasized the importance of our ecosystem in addressing chronic illnesses through innovative solutions like the Type 1 Diabetes Moonshot.     Innovating in Alzheimer’s disease? Learn how you can join our Alzheimer’s Moonshot. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox. Innovators: Health Transformer University fuels your health moonshot Funders: Become a Health Moonshot Champion

  4. 9 AUG

    An Insider’s Perspective on the Near Future of Alzheimer’s Care

    "Academia is a great area and fosters innovation, but then taking that science and translating it into something that can actually impact human health has a number of challenges. So trying to understand what those barriers are and how we can help bridge them is something that we have been able to do at ADDF and in collaboration with StartUp Health." In this episode of StartUp Health NOW, we chat with Laura Nisenbaum, PhD, Executive Director of Drug Development at the Alzheimer's Drug Discovery Foundation (ADDF). Organizations like ADDF are working to translate scientific research into real patient impact, particularly in the field of Alzheimer's disease, by funding innovative ventures and supporting startups in the biotech space. Dr. Nisenbaum talks with us about new Alzheimer’s tests and therapeutics and pulls back the curtain on how ADDF supports startups. Key Insights: We are at a tipping point in Alzheimer’s. Our ability to predict and detect – and then treat – Alzheimer’s disease is growing faster than ever. Dr. Laura Nisenbaum was involved in the launch of StartUp Health's Alzheimer's Moonshot, a collaboration with The Gates Foundation and ADDF, which is important for advancing research in the field of Alzheimer's disease. Academia fosters innovation, but translating scientific work into real patient impact poses challenges that need to be understood and bridged. Venture philanthropy model enables funding for innovators who may not receive funding from for-profit companies, allowing for more risky endeavors. The Diagnostics Accelerator challenges the research community to develop cutting-edge biomarkers and explore novel diagnostic technologies that will aid in Alzheimer’s diagnosis and clinical trial design. The potential for AI to revolutionize Alzheimer's research and diagnosis is evident in the funding and support for innovative companies in the field. Focusing on the biology of aging, including inflammation and mitochondrial dysfunction, could be key in developing novel therapies for Alzheimer's disease. The field of Alzheimer's research and care is at an amazing point with the first demonstration of some efficacy for drugs and a huge innovation curve from a biomarkers and diagnostics perspective. We can now detect amyloid in the brain through blood tests, marking an amazing point of innovation in the field of Alzheimer's research. Pursue innovative ideas with great gusto and perseverance, and take advantage of the incredible network of mentors and collaborators to thrive in the biotech and startup space. The momentum is building in the field of Alzheimer's research, thanks to the support from organizations like ADDF.     Innovating in Alzheimer’s disease? Learn how you can join our Alzheimer’s Moonshot. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox. Innovators: Health Transformer University fuels your health moonshot Funders: Become a Health Moonshot Champion

About

StartUp Health NOW celebrates the innovators, industry leaders, and entrepreneurs who are reimagining health and wellness.

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes and get the latest updates.

Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada